Cargando…
Mechanisms underlying restoration of hepatic insulin sensitivity with CB1 antagonism in the obese dog model
Visceral fat has long been associated with the development of insulin resistance. Although the mechanism is not well understood, it has been suggested that an increase in this fat depot results in an elevation in portal vein levels of free fatty acids and/or adipokines, adversely affecting hepatic g...
Autor principal: | Kim, Stella P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661137/ https://www.ncbi.nlm.nih.gov/pubmed/23700552 http://dx.doi.org/10.4161/adip.21890 |
Ejemplares similares
-
Cutting Calories and TXNIP From the Skeletal Muscle to Restore Insulin Sensitivity
por: Anderson, Ethan J.
Publicado: (2016) -
Glucocorticoid Receptor Antagonism as a New “Remedy” for Insulin Resistance—Not There Yet!
por: Varlamov, Elena V, et al.
Publicado: (2021) -
Decreasing CB(1) receptor signaling in Kupffer cells improves insulin sensitivity in obese mice
por: Jourdan, Tony, et al.
Publicado: (2017) -
Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
por: Deveaux, Vanessa, et al.
Publicado: (2009) -
New role of phenothiazine derivatives as peripherally acting CB1 receptor antagonizing anti-obesity agents
por: Sharma, Mayank Kumar, et al.
Publicado: (2018)